Addition of central obesity criteria increases the prevalence of clinical obesity in women with polycystic ovary syndrome

Authors

Keywords:

Obesity, Polycystic ovary syndrome, Central obesity, Waist circumference, Waist/hip ratio, Waist/height ratio

Abstract

Background: The Lancet Diabetes & Endocrinology Commission 2025 has recommended a newer definition and diagnostic criteria for clinical obesity. The impact of this newer definition has not been evaluated among women with polycystic ovary syndrome (PCOS).

Objectives: To determine and compare the frequency of obesity with previous and newer definitions among women with PCOS

Methods: This cross-sectional study included 765 adult women [age (years): 23.8 ±4.5; BMI (kg/m2): 27.7 ± 5.3; mean ± SD] with (newly diagnosed/ untreated for at least three months) PCOS based on the Rotterdam criteria from a University hospital in South Asia. Participants’ height, weight, waist circumference (WC), and hip circumference were measured. Body mass index (BMI), waist/hip ratio (WHR), and waist/height (WHtR) were calculated. Three BMI cut-offs of 23.0, 25.0, and 27.5 kg/m2 were considered. The cut-off of WC, WHR, and WHtR were 80 cm, 0.85, and 0.5, respectively. The following two criteria were used to define obesity: i) BMI + WC/WHR/WHtR, and ii) any two from WC, WHR, & WHtR regardless of BMI. Additionally, blood pressure (BP), glycemic status (fasting & OGTT glucose, HbA1C), and lipid profile (triglyceride & HDL-cholesterol) were considered for clinical obesity.

Results: Using the BMI cut-offs of 23, 25, and 27.5 kg/m2, the prevalence of obesity was 82.1%, 67.5%, and 47.1%, respectively. Using the current definition, the prevalence of obesity was 80.5%, 81.4%, and 79.4%, respectively, for the three BMI cut-offs, resulting in increases in prevalence of 1.8%, 20.7%, and 68.6%, respectively. All participants with obesity had clinical obesity, as the presence of PCOS indicates an ongoing illness. Besides, a significant portion had arterial hypertension, dysglycemia, and lipid abnormalities.

Conclusions: The Presence of higher central obesity (WC, WHR, WHtR) than generalized obesity (BMI) paradoxically increased the diagnosis of clinical obesity among South-Asian women with PCOS.

[J Assoc Clin Endocrinol Diabetol Bangladesh, 2024;3(Suppl 1): S64]

Abstract
604
PDF
110

Downloads

Published

2025-10-29

How to Cite

Addition of central obesity criteria increases the prevalence of clinical obesity in women with polycystic ovary syndrome. (2025). Journal of Association of Clinical Endocrinologist and Diabetologist of Bangladesh, 4(20), S64. https://doi.org/10.3329/jacedb.v4i20.84977

Issue

Section

Abstract of free paper - poster presentation

How to Cite

Addition of central obesity criteria increases the prevalence of clinical obesity in women with polycystic ovary syndrome. (2025). Journal of Association of Clinical Endocrinologist and Diabetologist of Bangladesh, 4(20), S64. https://doi.org/10.3329/jacedb.v4i20.84977

Most read articles by the same author(s)

1 2 3 4 5 > >>